The efficacy and safety of anti-PD-1 antibody toripalimab combined with surufatinib in neoadjuvant treatment of locally advanced thyroid cancer: A phase II study.

被引：0
|
作者：
Chen, Jiaying
Ji, Qinghai
Wang, Yu
Huang, Naisi
Hu, Jiaqian
Wei, Wenjun
Huang, Caiping
Shen, Qiang
Li, Duanshu
机构：
[1] Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China
[2] Fudan Univ, Dept Head & Neck Surg, Shanghai Canc Ctr, Shanghai, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6084
引用
收藏
页数：1
相关论文
共 50 条
  • [1] The Efficacy and Safety of Surufatinib Combined with Anti PD-1 Antibody Toripalimab in Neoadjuvant Treatment of Locally Advanced Differentiated Thyroid Cancer: A Phase II Study
    Chen, Jia-ying
    Huang, Nai-si
    Wei, Wen-jun
    Hu, Jia-qian
    Cao, Yi-ming
    Shen, Qiang
    Lu, Zhong-wu
    Wang, Yu-long
    Wang, Yu
    Ji, Qing-hai
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (12) : 7172 - 7180
  • [2] The Efficacy and Safety of Surufatinib Combined with Anti PD-1 Antibody Toripalimab in Neoadjuvant Treatment of Locally Advanced Differentiated Thyroid Cancer: A Phase II Study
    Jia-ying Chen
    Nai-si Huang
    Wen-jun Wei
    Jia-qian Hu
    Yi-ming Cao
    Qiang Shen
    Zhong-wu Lu
    Yu-long Wang
    Yu Wang
    Qing-hai Ji
    Annals of Surgical Oncology, 2023, 30 : 7172 - 7180
  • [3] ASO Visual Abstract: The Efficacy and Safety of Surufatinib Combined with Anti PD-1 Antibody Toripalimab in Neoadjuvant Treatment of Locally Advanced Differentiated Thyroid Cancer: A Phase II Study
    Chen, Jia-ying
    Huang, Nai-si
    Wei, Wen-jun
    Hu, Jia-qian
    Cao, Yi-ming
    Shen, Qiang
    Lu, Zhong-wu
    Wang, Yu-long
    Wang, Yu
    Ji, Qing-hai
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (04) : 2366 - 2367
  • [4] The sequence of chemotherapy and anti-PD-1 antibody influence the efficacy of neoadjuvant immunochemotherapy in locally advanced esophageal squamous cell cancer: A phase II study.
    Zhao, Lingdi
    Xing, Wenqun
    Yang, Yonghao
    Zhang, Yong
    Ma, Baozhen
    Fu, Xiaomin
    Liang, Guanghui
    Shang, Yiman
    Wang, Zibing
    Lin, Hongwei
    Gao, Quanli
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [5] Safety and Tolerability of Neoadjuvant Radiotherapy Combined With Anti-PD-1 Antibody Toripalimab for Locally Advanced, Resectable Esophageal Squamous Cell Cancer: A Prospective Phase IB Trial
    Sun, H.
    Yang, W.
    Luo, J.
    Lin, H.
    Zhou, T.
    Gong, H.
    Zhao, D.
    Niu, Z.
    Liu, B.
    Wang, Z.
    Li, B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : S102 - S103
  • [6] Efficacy and safety of anti-PD-1 antibody plus chemoradiotherapy in locally advanced esophageal squamous cancer
    Ma, Ji
    Yao, Nan
    Lu, Jiaying
    Qu, Wanxi
    Cui, Li
    Yuan, Shiwang
    Li, Na
    Tong, Shaodong
    Qin, Zhaohui
    Yao, Yuanhu
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [7] Phase II clinical trial of neoadjuvant anti-PD-1 (toripalimab) combined with axitinib in resectable mucosal melanoma
    Wu, N.
    Li, M.
    Zheng, H.
    Gao, M.
    Wang, D.
    Tian, H.
    Si, L.
    Chen, X.
    Chi, Z.
    Lai, Y.
    Sun, T.
    Zhang, Q.
    Long, G. V.
    Guo, J.
    Cui, C.
    ANNALS OF ONCOLOGY, 2024, 35 (02) : 211 - 220
  • [8] RC48-ADC combined with toripalimab, an anti-PD-1 monoclonal antibody (Ab), in patients with locally advanced or metastatic urothelial carcinoma (UC): Preliminary results of a phase Ib/II study.
    Zhou, Li
    Xu, Huayan
    Yan, Xieqiao
    Chi, Zhihong
    Cui, Chuanliang
    Si, Lu
    Tang, Bixia
    Mao, Lili
    Lian, Bin
    Wang, Xuan
    Li, Siming
    Bai, Xue
    Guo, Jun
    Sheng, Xinan
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [9] Safety and efficacy of YBL-006, an anti-PD-1 monoclonal antibody in advanced solid tumors: A phase I study.
    Oh, Do-Youn
    Park, John J.
    Lee, Keun Wook
    Kim, Seung Tae
    Sriuranpong, Virote
    Rha, Sun Young
    Yoo, Changhoon
    Keam, Bhumsuk
    Sabanathan, Dhanusha
    Kim, Se Hyun
    Park, Joon Oh
    Parinyanitikul, Napa
    Kim, Min Hwan
    Kim, Kyu-Pyo
    Kim, Myungsuk
    Yoon, Jaebong
    Lee, Han Seung
    Ock, Chan-Young
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [10] Phase II study of the safety and efficacy of the anti-PD-1 antibody balstilimab in patients with recurrent and/or metastatic cervical cancer
    O'Malley, David M.
    Oaknin, Ana
    Monk, Bradley J.
    Selle, Frederic
    Rojas, Carlos
    Gladieff, Laurence
    Berton, Dominique
    Leary, Alexandra
    Moore, Kathleen N.
    Estevez-Diz, Maria D. P.
    Hardy-Bessard, Anne-Claire
    Alexandre, Jerome
    Opperman, Christina P.
    de Azevedo, Carla Rameri A. S.
    Randall, Leslie M.
    Feliu, Waldo Ortuzar
    Ancukiewicz, Marek
    Ray-Coquard, Isabelle
    GYNECOLOGIC ONCOLOGY, 2021, 163 (02) : 274 - 280
12345